TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Clinical trial NCT07052903 · RECRUITING
Trial details
- NCT number
- NCT07052903
- Sponsor
- Alnylam Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2030-05-28
- Enrollment
- 1750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.